Literature DB >> 25541549

The place of experimental design and statistics in the 3Rs.

Richard M A Parker, William J Browne.   

Abstract

The 3Rs--replacement, reduction, and refinement--can be applied to any animal experiment by researchers and other bodies seeking to conduct those studies in as humane a manner as possible. Key to the success of this endeavor is an appreciation of the principles of good experimental design and analysis; these need to be considered in concert before any data is collected. Indeed, many of the principles central to helping achieve the objectives of the 3Rs-such as conducting valid, reliable, and efficient experiments; clearly and transparently reporting findings; and ensuring that an appreciation and understanding of animal welfare plays a central role in laboratory practice-are to the betterment of research per se.
© The Author 2014. Published by Oxford University Press on behalf of the Institute for Laboratory Animal Research. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Keywords:  3Rs; animal welfare; experimental design; laboratory animals; reduction; refinement; replacement; statistics

Mesh:

Year:  2014        PMID: 25541549     DOI: 10.1093/ilar/ilu044

Source DB:  PubMed          Journal:  ILAR J        ISSN: 1084-2020


  11 in total

1.  Experimental design and analysis and their reporting: new guidance for publication in BJP.

Authors:  Michael J Curtis; Richard A Bond; Domenico Spina; Amrita Ahluwalia; Stephen P A Alexander; Mark A Giembycz; Annette Gilchrist; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Andrew J Lawrence; David J MacEwan; Lawrence D F Moon; Sue Wonnacott; Arthur H Weston; John C McGrath
Journal:  Br J Pharmacol       Date:  2015-07       Impact factor: 8.739

2.  More than 3Rs: the importance of scientific validity for harm-benefit analysis of animal research.

Authors:  Hanno Würbel
Journal:  Lab Anim (NY)       Date:  2017-03-22       Impact factor: 12.625

3.  Welfare and Scientific Considerations of Tattooing and Ear Tagging for Mouse Identification.

Authors:  Johnny V Roughan; Tatum Sevenoaks
Journal:  J Am Assoc Lab Anim Sci       Date:  2019-02-27       Impact factor: 1.232

Review 4.  Imaging in experimental models of diabetes.

Authors:  Andrea Coppola; Giada Zorzetto; Filippo Piacentino; Valeria Bettoni; Ida Pastore; Paolo Marra; Laura Perani; Antonio Esposito; Francesco De Cobelli; Giulio Carcano; Federico Fontana; Paolo Fiorina; Massimo Venturini
Journal:  Acta Diabetol       Date:  2021-11-15       Impact factor: 4.280

Review 5.  Interim analysis: A rational approach of decision making in clinical trial.

Authors:  Amal Kumar; Bhaswat S Chakraborty
Journal:  J Adv Pharm Technol Res       Date:  2016 Oct-Dec

6.  Researchers' attitudes to the 3Rs-An upturned hierarchy?

Authors:  Nuno Henrique Franco; Peter Sandøe; I Anna S Olsson
Journal:  PLoS One       Date:  2018-08-15       Impact factor: 3.240

7.  Polygonogram and isobolographic analysis of interactions between various novel antiepileptic drugs in the 6-Hz corneal stimulation-induced seizure model in mice.

Authors:  Jarogniew J Luszczki; Anna Panasiuk; Mirosław Zagaja; Sławomir Karwan; Hubert Bojar; Zbigniew Plewa; Magdalena Florek-Łuszczki
Journal:  PLoS One       Date:  2020-06-01       Impact factor: 3.240

8.  A refinement to the formalin test in mice.

Authors:  Douglas M Lopes; Heather L Cater; Matthew Thakur; Sara Wells; Stephen B McMahon
Journal:  F1000Res       Date:  2019-06-20

9.  Learning process and improvement of point-of-care ultrasound technique for subxiphoid visualization of the inferior vena cava.

Authors:  Mauricio Gómez Betancourt; José Moreno-Montoya; Ana-María Barragán González; Juan Carlos Ovalle; Yury Forlan Bustos Martínez
Journal:  Crit Ultrasound J       Date:  2016-03-31

10.  Analyzing Clustered Data: Why and How to Account for Multiple Observations Nested within a Study Participant?

Authors:  Erika L Moen; Catherine J Fricano-Kugler; Bryan W Luikart; A James O'Malley
Journal:  PLoS One       Date:  2016-01-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.